Branch Retinal Vein Occlusion

Ophthalmology
1
Pipeline Programs
2
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
1
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Regeneron
RegeneronTARRYTOWN, NY
1 program
1
Macular Laser PhotocoagulationPhase 3
AB
AP BiosciencesTaiwan - Taipei
1 program
Aflibercept Injection [Eylea]N/A1 trial
Active Trials
NCT03651011CompletedEst. Oct 2021

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
AP BiosciencesAflibercept Injection [Eylea]

Clinical Trials (1)

NCT03651011AP BiosciencesAflibercept Injection [Eylea]

Navigated Laser In Branch Retinal Vein Occlusion Study

Start: Aug 2018Est. completion: Oct 2021
N/ACompleted

Related Jobs in Ophthalmology

Lead Data Manager

Genomics
Remote
8h ago

Cleanroom and Laboratory Technician

SAB BIO
9h ago

APAC Regulatory Affairs Manager

Johnson & Johnson
Singapore, Singapore
Yesterday

Clinical Operations Manager

Johnson & Johnson
Irvine, California, United States of America
Yesterday
$117K - $201K/yr

Site Delivery Leader MLL

Johnson & Johnson
Gent, East Flanders, Belgium
Yesterday

BM 喀什 PSR HY

Johnson & Johnson
Urumqi, Xinjiang, China
Yesterday

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 late-stage (Phase 3) programs — potential near-term approvals
2 companies competing in this space

Related Indications

Myopia(127)Cataract(116)Open-Angle Glaucoma(102)Glaucoma(92)Dry Eye(74)Age-Related Macular Degeneration(73)Dry Eye Disease(43)Neovascular Age-related Macular Degeneration(40)Macular Degeneration(37)Diabetic Retinopathy(25)